Clinical trials: Neuropsychiatric Symptom
- Condition Neuropsychiatric Symptom
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Neuropsychiatric Symptoms Related to Neurodegenerative Disease
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease
The purpose of this study is to assess the safety and tolerability of pimavanserin compared to placebo in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease.
- Trial name
- NCT03575052
- Testing
- Pimavanserin
- Where
- 104 sites in United States, Bulgaria and 10 more
- Volunteers
- 784 people
- Sponsor
- ACADIA Pharmaceuticals Inc.
Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
The purpose of this study is to evaluate the long-term safety and tolerability of pimavanserin in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease exposed to open-label pimavanserin…
- Trial name
- NCT03623321
- Testing
- Pimavanserin
- Where
- 88 sites in United States, Bulgaria and 10 more
- Volunteers
- 595 people
- Sponsor
- ACADIA Pharmaceuticals Inc.